-
August 20, 2015 Lupin receives FDA approval for Fenofibrate Tablets, 54 mg and 160 mg
-
August 7, 2015 Lupin Announces New Center of Excellence for Inhalation Research in Florida
-
July 24, 2015 Lupin Acquires Specialty Product Portfolio in Germany
-
July 23, 2015 Lupin Limited – Quarter I Results, FY2016
-
July 23, 2015 Lupin Acquires GAVIS to Expand US Generic Business
-
July 2, 2015 Lupin Acquires Biocom in Russia
-
May 13, 2015 Quarter IV and Annual Results, FY 2014-15 FY 2014-15 Net Sales up 13.6%, EBITDA up 23.7%, Net profit up 30.9%
-
May 13, 2015 Lupin Acquires Medquímica in Brazi
-
April 20, 2015 Lupin Launches Zaxine® in Canada
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications